Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGBD vs PSEC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CGBD Captures Overall Composite Edge (51.3 HOLD vs 46.7 HOLD), While PSEC Leads 3–2 on Growth & Valuation Pillars

CGBD Overall Winner 6-Pillar Tally: CGBD 2 – 3 PSEC (1 Tie) Matrix Metrics: CGBD 6 – 4 PSEC

As of Nov 16, 2026, Carlyle Secured Lending, Inc. (CGBD) captures the overall head-to-head institutional edge over Prospect Capital Corporation (PSEC) on higher Unified Composite conviction (51.3/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while PSEC wins 3–2 across the 6-pillar growth and valuation breakdown. CGBD trades at $10.90 (7.4x Forward P/E, 74.0% operating margin) versus PSEC at $1.33 (4.2x Forward P/E, 71.1% operating margin).

  • Growth vs. Quality Trade-Off: CGBD earns the overall head-to-head edge with a stronger Unified Composite Score (51.3/100 HOLD vs. PSEC 46.7/100 HOLD) and 0.44β · 24% Vol risk profile, whereas PSEC leads top-line expansion (-3.7% YoY revenue growth, 1.55x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CGBD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile PSEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGBD vs PSEC
CGBD NASDAQ Head-to-Head Winner
Carlyle Secured Lending, Inc. Common Stock
Institutional Equity
$10.90
-1.62% 1D
Market Cap $750.2M
TTM Revenue $260M
Forward P/E 7.4x
Beta / 30D Vol 0.44β · 24% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 37.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.3%) with fading momentum, RSI 50
RSI-14: 49.8 · SMA20: $10.79 · SMA50: $10.90
PSEC NASDAQ
Prospect Capital Corporation
Institutional Equity
$1.33
-8.89% 1D
Market Cap $782.6M
TTM Revenue $634M
Forward P/E 4.2x
Beta / 30D Vol 0.86β · 63% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -14.8%), weak momentum, RSI 33
RSI-14: 32.9 · SMA20: $1.49 · SMA50: $1.80

6-Pillar Scorecard Institutional Category Breakdown (CGBD 2 – 3 PSEC)

Columns: Metric · CGBD · PSEC
1. Valuation Multiples PSEC
Forward P/E 7.4x 4.2x
Trailing P/E 21.6x 9.4x
PEG Ratio 3.54x 1.55x
EV / Revenue 2.9x 1.2x
2. Growth & Scale PSEC
Revenue Growth (YoY) -7.7% -3.7%
Earnings Growth (YoY) -40.5% -78.2%
TTM Revenue (USD) $260M $634M
Market Cap $750.2M $782.6M
3. Profitability & Quality CGBD
Gross Margin 100.0% 100.0%
Operating Margin 74.0% 71.1%
Net Profit Margin 14.3% 8.5%
Return on Equity (ROE) 3.2% 1.2%
4. Balance Sheet & Cash Flow CGBD
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $16.26 Book/Sh · 3.2% ROE $5.36 Book/Sh · 1.2% ROE
Dividend Yield None (0.00%) 34.67%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 24.9% (65th %ile) 26.1% (<1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat PSEC
OpEx & R&D Intensity 26.0% of Rev ($67M) 28.9% of Rev ($183M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGBD (6) vs PSEC (4)
Institutional Metric CGBD PSEC Criterion Row Edge
Market Capitalization
Scale
$750.2M $782.6M Larger Scale PSEC
Trailing P/E Ratio
Valuation
21.6x 9.4x Lower Multiple PSEC
Forward P/E Ratio
Valuation
7.4x 4.2x Lower Multiple PSEC
Revenue Growth (YoY)
Growth
-7.7% -3.7% Higher Growth PSEC
Operating Margin (TTM)
Profitability
74.0% 71.1% Higher Margin CGBD
Net Profit Margin
Profitability
14.3% 8.5% Higher Margin CGBD
Return on Equity (ROE)
Capital Efficiency
3.2% 1.2% Higher ROE CGBD
52-Week Range Position
Momentum
29% ($10–$13) 2% ($1–$3) Stronger Trend CGBD
Beta / 30D Volatility
Risk Regime
0.44β · 24% Vol 0.86β · 63% Vol Lower Realized Risk CGBD
Unified Institutional Score
Composite Signal
51.3 / 100 (HOLD) 46.7 / 100 (HOLD) Higher Composite CGBD
Trailing 12M Revenue (USD)
Operating Scale
$260M $634M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.54x PEG · 2.9x EV/Rev 1.55x PEG · 1.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($16.26 Book/Sh · 3.2% ROE) N/A ($5.36 Book/Sh · 1.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CGBD +21.77 pp
CGBD: +4.91% · PSEC: -16.86%
3M Horizon CGBD +38.11 pp
CGBD: -2.77% · PSEC: -40.88%
6M Horizon CGBD +39.08 pp
CGBD: -0.18% · PSEC: -39.26%
1Y Horizon CGBD +43.29 pp
CGBD: -8.86% · PSEC: -52.15%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGBD vs PSEC. Trailing 12-month operating profitability (CGBD 74.0% vs PSEC 71.1%) and valuation multiples (CGBD 7.4x vs PSEC 4.2x Forward P/E) are benchmarked directly in Pillar 4 below.

CGBD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$260M
Gross Margin100.0%
Op. Margin74.0%
ROE / Fwd P/E3.2% · 7.4x
PSEC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$634M
Gross Margin100.0%
Op. Margin71.1%
ROE / Fwd P/E1.2% · 4.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGBD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 24.9%
IV Percentile 65th %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CGBD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PSEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 26.1%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PSEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGBD Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $750.2M market capitalization and 74.0% operating margin.
OpEx & R&D Reinvestment 26.0% of Rev ($67M)
90D Engineering Disclosures 0 Published
PSEC Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $782.6M market capitalization and 71.1% operating margin.
OpEx & R&D Reinvestment 28.9% of Rev ($183M)
90D Engineering Disclosures 0 Published

Investor FAQ CGBD vs PSEC Key Questions & Quantitative Answers

As of Nov 16, 2026, Carlyle Secured Lending, Inc. (CGBD) captures the overall head-to-head institutional edge over Prospect Capital Corporation (PSEC) on higher Unified Composite conviction (51.3/100 HOLD vs. 46.7/100 HOLD) after splitting the core matrix 6–4 (led by Profitability & Quality, Balance Sheet & Cash Flow), while PSEC wins 3–2 across the 6-pillar growth and valuation breakdown. CGBD trades at $10.90 (7.4x Forward P/E, 74.0% operating margin) versus PSEC at $1.33 (4.2x Forward P/E, 71.1% operating margin). Growth vs. Quality Trade-Off: CGBD earns the overall head-to-head edge with a stronger Unified Composite Score (51.3/100 HOLD vs. PSEC 46.7/100 HOLD) and 0.44β · 24% Vol risk profile, whereas PSEC leads top-line expansion (-3.7% YoY revenue growth, 1.55x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CGBD is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile PSEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PSEC leads the Growth & Scale pillar: CGBD posts -7.7% YoY revenue growth and -40.5% YoY earnings growth on $260M TTM revenue (100.0% gross margin, 74.0% operating margin), compared with PSEC at -3.7% YoY revenue growth and -78.2% YoY earnings growth on $634M TTM revenue (100.0% gross margin, 71.1% operating margin). On trailing 12-month operating scale, CGBD generates $260M in USD-normalized revenue versus $634M for PSEC. In operating R&D and SG&A reinvestment, CGBD deploys 26.0% of Rev ($67M) (0 90-day corporate R&D disclosures) versus 28.9% of Rev ($183M) (0 disclosures) for PSEC.

PSEC screens cheaper on headline valuation multiples. CGBD trades at 7.4x Forward P/E, 21.6x Trailing P/E, 3.54x PEG, and 2.9x EV/Revenue (unreported cash flow margin), whereas PSEC trades at 4.2x Forward P/E, 9.4x Trailing P/E, 1.55x PEG, and 1.2x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGBD (3.2% ROE) versus PSEC (1.2% ROE) capital efficiency.

In options market volatility and institutional positioning, CGBD carries 24.9% implied volatility (65th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 24% Vol realized risk). By comparison, PSEC carries 26.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 63% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.